Akoya Biosciences
Akoya Biosciences Q1 Revenues Rise 38 Percent
The company posted revenues of $16.9 million, up from $12.2 million in the year-ago period and above the consensus Wall Street estimate of $14.9 million.
Companies including Bruker, Akoya, and Standard BioTools either released new platforms or highlighted advances in their systems' capabilities at the meeting.
The Marlborough, Massachusetts-based 3D omics company provided a business outlook for the current year and beyond in a call recapping 2021 earnings.
Akoya Biosciences Q4 Revenues Rise 26 Percent
The spatial biology firm posted revenues of $16.2 million in the fourth quarter, up from $12.9 million in the year-ago period, and placed a total of 46 instruments.
Jan 20, 2022
Nov 8, 2021
Akoya Biosciences Q3 Revenues Rise 35 Percent
May 18, 2021
Akoya Biosciences Q1 Revenues Rise 11 Percent
Dec 5, 2019